ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 37

Follicular Entry Of Lymphotoxin-Expressing B Cells Via Type I Interferon Disrupts Marginal Zone Barrier Integrity and Exacerbates Systemic Autoimmunity

Hao Li1, Hui-Chen Hsu2, Qi Wu3, Jun Li3, PingAr Yang3, Yang-Xin Fu4 and John D. Mountz5, 1Dept. Med - Immunology/Rheumatology division, University of Alabama at Birmingham, Birmingham, AL, 2Birmingham VA Medical Center, Birmingham, AL, 3Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 4Department of Pathology, The University of Chicago, Chicago, IL, 5Dept of Med/Rheumatology Div, University of Alabama at Birmingham, Birmingham, AL

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: autoantibodies, autoantigens, B cells, interferons and macrophages

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: B cell Function and Targeting in Systemic Lupus Erythematosus

Session Type: Abstract Submissions (ACR)

Background/Purpose: Marginal zone macrophages (MZMs), a small subset of specialized splenic macrophages located in the MZ, act as final follicular entry barrier to clear apoptotic cells (ACs) to prevent AC antigens (Ags) entering to the spleen follicles.  We recently reported reduced tolerogenic function, frequency and numbers of MZMs in the spleen of lupus prone BXD2 mice. Loss of MZMs were further confirmed in B6 Sle1.Sle2.Sle3 mice and lupus patients. Expression of lymphotoxin (LT) by B cells has been implicated as a critical factor to maintain MZMs. The present study investigated how type I interferons (IFNs) dissociated this interaction and induced MZM loss in lupus.

Methods: Confocal microscope and FACS analysis were carried out to determine the percentages and location of of MZMs, B cells and the distribution of LT and its receptor (LTβR) in the spleen. A mixed bone marrow (BXD2-GFP+Ifnαr+/+:BXD2-GFP–Ifnαr-/- =1:1) reconstitution in BXD2 Rag2-/-  mice was carried out to determine if type I IFNs affect MZ integrity through direct action on MZMs or indirectly by affecting B cells.  LT-LTβR interaction in vivo was disrupted by repeated injection of mice with a low dose of LTR fusion protein (LTR:Fc, 15 ug/mouse per week, 4 weeks) or by administrations of CpG (2.5 ug/mouse, every other day for 2 weeks).

Results: Repeated injections of CpG to B6, but not B6-Ifnαr-/- mice, induced loss of MZMs. Consistent with this, the spontaneous loss of MZMs and the elevated autoantibodies against MZM Ags, Marco and scavenger receptor A, in BXD2 mice were prevented in the absence of type I IFN signaling.  Marginal zone B cells (MZs) are the major LT expressing cells in the marginal zone. Although there was comparable expression of LT, MZs were mainly localized in the follicles in BXD2 mice but in the marginal zone in both B6 and BXD2-Ifnαr-/- mice. BM reconstitution experiment further shows that the absence of type I IFNR did not directly affect MZM repopulation, but rather affected MZ B cell distribution. GFP+Ifnαr+/+ B cells mainly migrated to the follicles whereas GFP–Ifnαr-/-B cells remained in the marginal zone and became the source of LT to support MZMs. Administration of a low dose of LTR:Fc to BXD2 mice selectively depleted MZMs and enhanced the spontaneous germinal center (GC) response without affecting follicular dendritic cell networks. 

Conclusion: Our present study suggests a novel mechanism associated with type I IFN-promoted immune response against apoptotic self-Ags as a result of follicular migration of LT expressing and self-antigen carrier B cells. The shift of LT expressing B cells from the MZ to the follicles by type I IFNs promoted apoptotic Ag delivery and LT stimulation to FDCs via breaking down the marginal zone barrier and finally exaggerated the production of pathogenic auto-antibodies.


Disclosure:

H. Li,
None;

H. C. Hsu,

None,

2;

Q. Wu,
None;

J. Li,

None,

2;

P. Yang,
None;

Y. X. Fu,
None;

J. D. Mountz,

None,

2.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/follicular-entry-of-lymphotoxin-expressing-b-cells-via-type-i-interferon-disrupts-marginal-zone-barrier-integrity-and-exacerbates-systemic-autoimmunity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology